ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Waseem Hassan and Amina Ara
Institute of Chemical Sciences, University of Peshawar, Peshawar 25120, Khyber Pakhtunkhwa, Pakistan.
J Pure Appl Microbiol. 2021;15(3):1211-1229 | Article Number: 7039
https://doi.org/10.22207/JPAM.15.3.11 | © The Author(s). 2021
Received: 10/05/2021 | Accepted: 17/06/2021 | Published: 28/06/2021
Abstract

The objective of the study was to perform a bibliometric analysis of the Pfizer-BioNTech vaccine. For this purpose Scopus database was used. As of 13th May 2021, one hundred and seventy-three (n=173) research documents are published about it. We used Vosviewer and Biblioshiny (Bibliometrix) in the present report. In all publications, 1160 authors have significantly contributed. The documents per author was 0.119, while authors per document was 8.41. Collaborative Index (CI) was found to be 9.47. By biblioshiny we also applied Lotka’s law to depict the author’s frequency. 1097 authors were involved in only one (n=1) publication. Based on the Scopus record, the highest documents are published by Dormitzer, P.R. (n=6). In universities and countries categories, Tel Aviv University (n=7) and USA (48) are the most productive. By Vosviewer the collaboration pattern among authors, institutes, and countries is graphically presented. For example, 28 authors, 17 departments and 7 countries directly contributed to one publication. The research documents (133) are published in 102 sources or journals. The highest documents are published in Vaccines (n=8), while the highest citations were recorded for the New England Journal of Medicine (n=838). We also applied co-words analysis to understand the main focus of these publications.

Keywords

Bibliometric analysis, COVID-19, Pfizer Vaccine

Article Metrics

Article View: 735

Share This Article

© The Author(s) 2021. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.